Carbamazepine toxicity resulting from generic substitution

Jamie T. Gilman, Luis A. Alvarez, Michael Duchowny

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Generic substitution is practiced widely in both hospital and community settings. There have been several reports of reduced serum concentrations and seizure exacerbation following generic substitution of Tegretol. We describe the first 2 cases of carbamazepine toxicity resulting from the substitution of Tegretol with Epitol. Two 6-year-old children experienced increases in the maximum serum carbamazepine concentration, one of 22% and one of 41%. Both became asymptomatic when their serum concentrations were lowered and had no residual effects.

Original languageEnglish
Pages (from-to)2696-2697
Number of pages2
JournalNeurology
Volume43
Issue number12
StatePublished - Dec 1 1993

Fingerprint

Drug Substitution
Carbamazepine
Serum
Seizures

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Gilman, J. T., Alvarez, L. A., & Duchowny, M. (1993). Carbamazepine toxicity resulting from generic substitution. Neurology, 43(12), 2696-2697.

Carbamazepine toxicity resulting from generic substitution. / Gilman, Jamie T.; Alvarez, Luis A.; Duchowny, Michael.

In: Neurology, Vol. 43, No. 12, 01.12.1993, p. 2696-2697.

Research output: Contribution to journalArticle

Gilman, JT, Alvarez, LA & Duchowny, M 1993, 'Carbamazepine toxicity resulting from generic substitution', Neurology, vol. 43, no. 12, pp. 2696-2697.
Gilman JT, Alvarez LA, Duchowny M. Carbamazepine toxicity resulting from generic substitution. Neurology. 1993 Dec 1;43(12):2696-2697.
Gilman, Jamie T. ; Alvarez, Luis A. ; Duchowny, Michael. / Carbamazepine toxicity resulting from generic substitution. In: Neurology. 1993 ; Vol. 43, No. 12. pp. 2696-2697.
@article{efb6b4a74ab04be8b15671f08a686f13,
title = "Carbamazepine toxicity resulting from generic substitution",
abstract = "Generic substitution is practiced widely in both hospital and community settings. There have been several reports of reduced serum concentrations and seizure exacerbation following generic substitution of Tegretol. We describe the first 2 cases of carbamazepine toxicity resulting from the substitution of Tegretol with Epitol. Two 6-year-old children experienced increases in the maximum serum carbamazepine concentration, one of 22{\%} and one of 41{\%}. Both became asymptomatic when their serum concentrations were lowered and had no residual effects.",
author = "Gilman, {Jamie T.} and Alvarez, {Luis A.} and Michael Duchowny",
year = "1993",
month = "12",
day = "1",
language = "English",
volume = "43",
pages = "2696--2697",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Carbamazepine toxicity resulting from generic substitution

AU - Gilman, Jamie T.

AU - Alvarez, Luis A.

AU - Duchowny, Michael

PY - 1993/12/1

Y1 - 1993/12/1

N2 - Generic substitution is practiced widely in both hospital and community settings. There have been several reports of reduced serum concentrations and seizure exacerbation following generic substitution of Tegretol. We describe the first 2 cases of carbamazepine toxicity resulting from the substitution of Tegretol with Epitol. Two 6-year-old children experienced increases in the maximum serum carbamazepine concentration, one of 22% and one of 41%. Both became asymptomatic when their serum concentrations were lowered and had no residual effects.

AB - Generic substitution is practiced widely in both hospital and community settings. There have been several reports of reduced serum concentrations and seizure exacerbation following generic substitution of Tegretol. We describe the first 2 cases of carbamazepine toxicity resulting from the substitution of Tegretol with Epitol. Two 6-year-old children experienced increases in the maximum serum carbamazepine concentration, one of 22% and one of 41%. Both became asymptomatic when their serum concentrations were lowered and had no residual effects.

UR - http://www.scopus.com/inward/record.url?scp=0027744313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027744313&partnerID=8YFLogxK

M3 - Article

C2 - 8255480

AN - SCOPUS:0027744313

VL - 43

SP - 2696

EP - 2697

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 12

ER -